The usage of Clinical Intelligence is becoming a common phenomenon in healthcare institutes worldwide and the Global Clinical Intelligence Market is poised to strike a splendid CAGR of 12.5% over the forecast period of 2017–2023, predicts Market Research Future (MRFR) in an exhaustive study. Clinical intelligence is a new learning paradigm for healthcare providers in which clinical data is analyzed with the use of modern data mining, data visualization, and predictive modeling tools to improve healthcare delivery.The pressing need to curb healthcare costs has been the primary drive motivating the growth of the global clinical intelligence market. The growing burden of chronic diseases and increasing patient influx in hospitals has raised the adoption of software solutions for tedious process such as insurance claim processing and fraud detection. This results in improved healthcare outcomes and subsequently boosts the growth of the market.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/4478Other factors stimulating the market growth include governments in multiple countries encouraging the adoption of clinical intelligence solutions. Furthermore, constant changes in regulations, increasing reporting mandates, and ever-increasing competition, healthcare organizations can no longer ignore the importance of clinical intelligence. Clinical intelligence aids healthcare sector to improve the quality of care by analyzing the gaps in their care, patient safety, efficiency, and cost-effectiveness.On the other hand, a general lack of regulatory and clinical standards for predictive analytics is likely to hinder the growth of the market. The high cost of clinical intelligence software might restrain the growth of the market growth in developing countries.Competitive LandscapeThe notable players in the clinical intelligence market include General Electric Company (U.S.), QSI Management, LLC (U.S.), Allscripts (U.S.), Cerner Corporation (U.S.), IBM (U.S.), Epic Systems Corporation (U.S.), Greenway Health, LLC (U.S.), McKesson Corporation (U.S.), and eClinicalWorks (U.S.).Browse Full Research Report at: https://www.marketresearchfuture.com/reports/clinical-intelligence-market-4478SegmentationThe global clinical intelligence market has been segmented based on component, type, end-user, and application.By type, the global clinical intelligence market has been segmented into population health management, retrospective performance measures & predictive analytics, clinical benchmarking, clinical decision support (CDSS) system, quality improvement, performance measurement systems, and others. The quality improvement segment has been further segmented into six sigma. The population health management segment has been further segmented into under-utilization of health services and over-utilization of health services.By component, the global clinical intelligence market has been segmented into hardware, software, and services.By application, the global clinical intelligence market has been segmented into revenue cycle management (RCM) claims, fraud, supply chain, financial management, clinical, and others.By end-users, the global clinical intelligence market has been segmented into clinics, hospitals, TPAs, and others.Regional AnalysisBy region, the global clinical intelligence market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).The Americas account for the maximum share of the global clinical intelligence market owing to high usage of software solutions for healthcare administration. The presence of healthcare IT companies in the region and high healthcare expenditure supports market growth in the region. Additionally, growing usage of Decision Support System among tertiary care centers in the US has proven to be beneficial for the growth of the market.Europe follows the Americas closely and is the second largest market for clinical intelligence. Increase in a number of healthcare institutions who are leveraging clinical intelligence management softwares and expanding healthcare expenditure boosts the market growth in Europe.APAC is poised to be the fastest growing market for clinical intelligence. Development of healthcare IT infrastructure, increasing healthcare expenditure and the growing presence of key players in the region can be credited for the growth of the market.The MEA market is expected to showcase moderate growth. The Africa region, in particular, will exhibit limited growth due to low healthcare penetration and low healthcare expenditure.About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.